John C. Kucharczuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John C. Kucharczuk has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
Joseph Friedberg
2 shared publicationsA. Marc Gillinov
1 shared publication- Abeel A. Mangi
Section of Cardiac Surgery, Yale University School of Medicine, New Haven, Connecticut
1 shared publication - Aditya Krishna Kaza
Department of Cardiac Surgery, Boston Children's Hospital, Boston, Massachusetts.; Department of Surgery, Harvard Medical School, Boston, Massachusetts.
1 shared publication - Alan Patrick Kypson
Department of Cardiovascular Sciences, Brody School of Medicine, East Carolina Heart Institute, East Carolina University, Greenville, NC 27834, USA
1 shared publication Alfred Chahine
1 shared publication
Latest Publications
- Open Access
- 14 July 2016
- Published by Springer Nature in Cardio-Oncology
- Vol. 2 (1) , 1-5
Persistent PR segment change in malignant pericardial disease
Electrocardiographic changes may manifest in patients with pericardial effusions. PR segment changes are frequently overlooked, but when present, can provide diagnostic significance. The diagnostic value of PR segment changes in determining benign versus malignant pericardial disease in cancer patients with pericardial effusions has not been investigated. We aimed to determine the relationship between PR segment changes and malignant pericardial disease in cancer patients presenting with pericardial effusions. Consecutive patients with active malignancy who underwent surgical subxiphoid pericardial window by a single thoracic surgeon between 2011 and 2014 were included in this study. A total of 104 pre- and post-operative ECGs were reviewed, and PR depression or elevation was defined by deviation of at least 0.5 millivolts from the TP segment using a magnifying glass. Pericardial fluid cytology, flow cytometry and tissue biopsy were evaluated. Baseline characteristics and co-morbidities were compared between cancer patients with benign and malignant pericardial effusions. A total of 26 patients with active malignancy and pericardial effusion who underwent pericardial window over the study period were included. Eighteen (69 %) patients had isoelectric PR segments, of whom none (0 %) had evidence of malignant pericardial disease (100 % negative predictive value). Eight (31 %) patients had significant ECG findings (PR segment depression in leads II, III and/or aVF as well as PR elevation in aVR/V1), all 8 (100 %) of whom had pathologically confirmed malignant pericardial disease (100 % positive predictive value). PR segment changes in all 8 patients persisted (up to 11 months) on post-operative serial ECGs. The PR segment changes had no relationship to heart rate or the time of atrial-ventricular conduction. In patients with active cancer presenting with pericardial effusion, the presence of PR segment changes is highly predictive of active malignant pericardial disease. When present, PR changes typically persist on serial ECGs even after pericardial window.
- 14 July 2016
- Published by Springer Nature in Cardio-Oncology
- Vol. 2 (1) , 1-5
Open AccessPersistent PR segment change in malignant pericardial disease
Electrocardiographic changes may manifest in patients with pericardial effusions. PR segment changes are frequently overlooked, but when present, can provide diagnostic significance. The diagnostic value of PR segment changes in determining benign versus malignant pericardial disease in cancer patients with pericardial effusions has not been investigated. We aimed to determine the relationship between PR segment changes and malignant pericardial disease in cancer patients presenting with pericardial effusions. Consecutive patients with active malignancy who underwent surgical subxiphoid pericardial window by a single thoracic surgeon between 2011 and 2014 were included in this study. A total of 104 pre- and post-operative ECGs were reviewed, and PR depression or elevation was defined by deviation of at least 0.5 millivolts from the TP segment using a magnifying glass. Pericardial fluid cytology, flow cytometry and tissue biopsy were evaluated. Baseline characteristics and co-morbidities were compared between cancer patients with benign and malignant pericardial effusions. A total of 26 patients with active malignancy and pericardial effusion who underwent pericardial window over the study period were included. Eighteen (69 %) patients had isoelectric PR segments, of whom none (0 %) had evidence of malignant pericardial disease (100 % negative predictive value). Eight (31 %) patients had significant ECG findings (PR segment depression in leads II, III and/or aVF as well as PR elevation in aVR/V1), all 8 (100 %) of whom had pathologically confirmed malignant pericardial disease (100 % positive predictive value). PR segment changes in all 8 patients persisted (up to 11 months) on post-operative serial ECGs. The PR segment changes had no relationship to heart rate or the time of atrial-ventricular conduction. In patients with active cancer presenting with pericardial effusion, the presence of PR segment changes is highly predictive of active malignant pericardial disease. When present, PR changes typically persist on serial ECGs even after pericardial window.
- 11 December 2013
- Published by Springer Nature in Current Surgery Reports
- Vol. 2 (1) , 1-8
Acute Management of Esophageal Perforation
- 11 December 2013
- Published by Springer Nature in Current Surgery Reports
- Vol. 2 (1) , 1-8
Acute Management of Esophageal Perforation
- 29 February 2012
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 22 (1) , 77-81
Chest Wall Sarcomas and Induction Therapy
- 29 February 2012
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 22 (1) , 77-81
Chest Wall Sarcomas and Induction Therapy
- 1 January 2010
- Published by Elsevier
Contributors
- 1 July 2009
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 88 (1) , 199
Invited Commentary
- 1 July 2009
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 88 (1) , 199
Invited Commentary
- 1 June 2005
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 17 (2) , 134-137
Radiofrequency Ablation: Emerging Therapy for the Small Pulmonary Nodule?
- 1 June 2005
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 17 (2) , 134-137
Radiofrequency Ablation: Emerging Therapy for the Small Pulmonary Nodule?
- 1 October 2003
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (4) , 1276-1278
Weerda diverticuloscope: novel use to remove embedded esophageal foreign bodies
- 1 October 2003
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (4) , 1276-1278
Weerda diverticuloscope: novel use to remove embedded esophageal foreign bodies
- 1 August 2003
- Vol. 9 (8) , 3080-97
Gene expression profiling of malignant mesothelioma.
Malignant mesothelioma is a uniformly fatal cancer of the pleural and peritoneal spaces. Several challenging clinical problems include poor understanding of the pathophysiology, inaccurate diagnosis from tissue samples, and unsuccessful treatment strategies. The purpose of this study was to use microarray analysis to identify specific gene expression changes in mesothelioma compared with normal mesothelium. We performed gene expression analysis on mesothelioma tissue specimens from 16 patients and compared these to 4 control pleural tissue samples using cDNA microarray filters with 4132 clones. Multiple normalization and analysis approaches were used. Quantitative reverse transcription-PCR and immunohistochemistry were used to validate results. Genes (166) were significantly up-regulated, and 26 were down-regulated. Validation of 18 genes using real-time PCR confirmed array predictions in every case. Analysis revealed activation of several key pathways including genes involved in glucose metabolism, mRNA translation, and cytoskeletal remodeling. Expression profiling identified processes likely responsible for 18-fluoro-2-deoxy-glucose uptake and tumor localization by positron emission tomography, and a role for hypoxia-inducible factor-1 was suggested. Potentially important up-regulated genes included gp96, lung resistance-related protein, galectin-3 binding protein, the M(r) 67,000 laminin receptor (on tumor vessels), and voltage-dependent anion channels. Prospective testing using reverse transcription-PCR confirmed up-regulation of these novel markers. Expression profiling revealed marked up-regulation of energy, protein translation, and cytoskeletal remodeling pathways in mesothelioma. Additional genes that could be important in our understanding of the pathogenesis of mesothelioma, aiding in diagnosis, or improving targets for therapy were also identified.
- 1 August 2003
- Vol. 9 (8) , 3080-97
Gene expression profiling of malignant mesothelioma.
Malignant mesothelioma is a uniformly fatal cancer of the pleural and peritoneal spaces. Several challenging clinical problems include poor understanding of the pathophysiology, inaccurate diagnosis from tissue samples, and unsuccessful treatment strategies. The purpose of this study was to use microarray analysis to identify specific gene expression changes in mesothelioma compared with normal mesothelium. We performed gene expression analysis on mesothelioma tissue specimens from 16 patients and compared these to 4 control pleural tissue samples using cDNA microarray filters with 4132 clones. Multiple normalization and analysis approaches were used. Quantitative reverse transcription-PCR and immunohistochemistry were used to validate results. Genes (166) were significantly up-regulated, and 26 were down-regulated. Validation of 18 genes using real-time PCR confirmed array predictions in every case. Analysis revealed activation of several key pathways including genes involved in glucose metabolism, mRNA translation, and cytoskeletal remodeling. Expression profiling identified processes likely responsible for 18-fluoro-2-deoxy-glucose uptake and tumor localization by positron emission tomography, and a role for hypoxia-inducible factor-1 was suggested. Potentially important up-regulated genes included gp96, lung resistance-related protein, galectin-3 binding protein, the M(r) 67,000 laminin receptor (on tumor vessels), and voltage-dependent anion channels. Prospective testing using reverse transcription-PCR confirmed up-regulation of these novel markers. Expression profiling revealed marked up-regulation of energy, protein translation, and cytoskeletal remodeling pathways in mesothelioma. Additional genes that could be important in our understanding of the pathogenesis of mesothelioma, aiding in diagnosis, or improving targets for therapy were also identified.